Montaner JSG - Search Results

Year	Number of Results
2002	28
2003	27
2004	27
2005	27
2006	41
2007	29
2008	31
2009	24
2010	29
2011	27
2012	24
2013	34
2014	45
2015	35
2016	26
2017	30
2018	18
2019	22
2020	10
2021	16
2022	24
2023	15
2024	9
2025	0

1

Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs.

Parashar S, Collins AB, Montaner JS, Hogg RS, Milloy MJ. Parashar S, et al. Curr Opin HIV AIDS. 2016 Sep;11(5):507-513. doi: 10.1097/COH.0000000000000297. Curr Opin HIV AIDS. 2016. PMID: 27254749 Free PMC article. Review.

2

Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Marshall BD, et al. Lancet. 2011 Apr 23;377(9775):1429-37. doi: 10.1016/S0140-6736(10)62353-7. Epub 2011 Apr 15. Lancet. 2011. PMID: 21497898

3

Treatment as prevention--where next?

Hull M, Lange J, Montaner JS. Hull M, et al. Curr HIV/AIDS Rep. 2014 Dec;11(4):496-504. doi: 10.1007/s11904-014-0237-5. Curr HIV/AIDS Rep. 2014. PMID: 25384357 Free PMC article. Review.

4

Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.

Zang X, Krebs E, Wang L, Marshall BDL, Granich R, Schackman BR, Montaner JSG, Nosyk B; Localized HIV modeling study group. Zang X, et al. Among authors: montaner jsg. Pharmacoeconomics. 2019 Oct;37(10):1219-1239. doi: 10.1007/s40273-019-00817-1. Pharmacoeconomics. 2019. PMID: 31222521 Free PMC article. Review.

5

Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world.

Wood E, Montaner JS, Bangsberg DR, Tyndall MW, Strathdee SA, O'Shaughnessy MV, Hogg RS. Wood E, et al. AIDS. 2003 Nov 21;17(17):2419-27. doi: 10.1097/00002030-200311210-00003. AIDS. 2003. PMID: 14600512 Review. No abstract available.

6

Ritonavir-boosted protease inhibitors in HIV therapy.

Hull MW, Montaner JS. Hull MW, et al. Ann Med. 2011 Aug;43(5):375-88. doi: 10.3109/07853890.2011.572905. Epub 2011 Apr 18. Ann Med. 2011. PMID: 21501034 Free article. Review.

7

A review of barriers and facilitators of HIV treatment among injection drug users.

Wood E, Kerr T, Tyndall MW, Montaner JS. Wood E, et al. AIDS. 2008 Jul 11;22(11):1247-56. doi: 10.1097/QAD.0b013e3282fbd1ed. AIDS. 2008. PMID: 18580603 Review.

8

Treatment as prevention: toward an AIDS-free generation.

Montaner JS. Montaner JS. Top Antivir Med. 2013 Jul-Aug;21(3):110-4. Top Antivir Med. 2013. PMID: 23981598 Free PMC article. Review.

9

48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.

Azar P, Wong JSH, Mathew N, Ignaszewski MJ, Partovi N, Krausz RM, Ajidahun A, Thotakura S, Harris M, Barrios R, Montaner JSG, Maharaj AR. Azar P, et al. Among authors: montaner jsg. J Addict Med. 2024 Jan-Feb 01;18(1):82-85. doi: 10.1097/ADM.0000000000001231. Epub 2023 Oct 17. J Addict Med. 2024. PMID: 37847573

10

Programmatic Implications of Acute and Early HIV Infection.

Suthar AB, Granich RM, Kato M, Nsanzimana S, Montaner JS, Williams BG. Suthar AB, et al. J Infect Dis. 2015 Nov 1;212(9):1351-60. doi: 10.1093/infdis/jiv430. Epub 2015 Aug 26. J Infect Dis. 2015. PMID: 26310309 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

546 results

Results by year